Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today announced that safety and efficacy ...

DURHAM, N.C., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent ...

For more information about the preclinical study and how works, visit . Atsena Therapeutics (“Atsena”) is a clinical-stage gene therapy company developing best-in-class treatments for the ...

Atsena Therapeutics ("Atsena”) is a clinical-stage gene therapy company developing best-in-class treatments for the reversal or prevention of blindness from inherited retinal diseases. The company's ...

Atsena Therapeutics Inc. is the business for which the check was intended. Investigators reported they spoke to the business owner, who said they were unaware they were missing a check.

SAR439483 is an investigational gene therapy developed by Atsena Therapeutics for Leber Congenital Amaurosis (LCA) caused by GUCY2D gene mutations. It utilizes an AAV-based vector to deliver a ...